Pan-Cancer Analysis Identifies DIP2B as a Potential Biomarker That Inhibits Kidney Renal Clear Cell Carcinoma

Yang Chen1,2, Yao Guo2, Ankang Hu1

  • 1Xuzhou Medical University, Xuzhou, Jiangsu, China.

IUBMB Life
|September 17, 2025
PubMed

Insights

Disco interacting protein 2 homolog B (DIP2B) is a gene with a dual role in cancer. High DIP2B expression can worsen survival in some cancers but improve it in others, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Disco interacting protein 2 homolog B (DIP2B) is a gene involved in crucial cellular processes.
  • Its specific role in cancer development and progression is not well understood.
  • Emerging evidence points to a potential involvement of DIP2B in tumorigenesis.

Purpose of the Study:

  • To comprehensively analyze DIP2B expression, dysregulation, and prognostic significance across various cancer types.
  • To investigate the molecular functions and clinical implications of DIP2B in cancer.
  • To evaluate DIP2B as a potential biomarker for cancer diagnosis and prognosis.

Main Methods:

  • Utilized TCGA, GTEx, and UALCAN databases for mRNA and protein expression analysis.
  • Investigated correlations between DIP2B expression and gene mutations, survival, DNA methylation, immune infiltration, TMB, and drug sensitivity.
  • Performed Gene Ontology (GO) and KEGG pathway analyses, along with experimental validation in cancer cell lines.

Main Results:

  • High DIP2B expression correlated with poor overall survival (OS) in BRCA, KICH, LUAD, MESO, SARC, and THCA, but improved OS in KIRC.
  • Elevated DIP2B levels were linked to adverse disease-specific survival (DSS) in ACC, MESO, and UVM.
  • DIP2B knockdown inhibited proliferation and migration in KIRC cells, while it promoted oncogenic functions in LUAD cells.

Conclusions:

  • DIP2B exhibits distinct roles in different cancer types, acting as a tumor suppressor in KIRC and an oncogene in LUAD.
  • DIP2B expression patterns and functions vary significantly across the cancer spectrum.
  • DIP2B holds potential as a prognostic and diagnostic biomarker, necessitating further investigation into its context-dependent roles.